secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K/A
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0001104659-23-089366
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ApolloMed Q2 revenue up 29% to $348.2M, net income +10%; guidance reaffirmed
----------------------------------------------------------------------------

- Total revenue $348.2M (+29% YoY); net income attributable to ApolloMed $13.2M (+10%); adjusted EBITDA $35.8M (+44%).
- Care Partners revenue $325.2M (+32%); segment operating income surged 250% to $27.8M.
- FY2023 guidance reaffirmed: total revenue $1.3B-$1.5B; adjusted EBITDA $120M-$160M; diluted EPS $0.95-$1.20.
- Agreed to acquire Texas Independent Providers (120+ PCPs); partnered with IntraCare (425+ providers) with $25M convertible note.
- Filing corrects balance sheet items: income taxes payable to $20.4M, total liabilities to $443.6M, mezzanine equity to $13.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/0001104659-23-089366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/tm2323203d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-089366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer